Campestanol

Campestanol is a lipid of Sterol Lipids (ST) class. The involved functions are known as Oxidation. The related lipids are campestanol, Sterols, campesterol and 6-oxocampestanol.

Cross Reference

Introduction

To understand associated biological information of Campestanol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Campestanol?

There are no associated biomedical information in the current reference collection.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with Campestanol

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Campestanol through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Campestanol?

There are no associated biomedical information in the current reference collection.

What functions are associated with Campestanol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Campestanol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Campestanol?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with Campestanol?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Campestanol

Download all related citations
Per page 10 20 50 100 | Total 70
Authors Title Published Journal PubMed Link
Weingärtner O et al. Differential effects on inhibition of cholesterol absorption by plant stanol and plant sterol esters in apoE-/- mice. 2011 Cardiovasc. Res. pmid:21257611
Lin Y et al. Triterpenic Acids Present in Hawthorn Lower Plasma Cholesterol by Inhibiting Intestinal ACAT Activity in Hamsters. 2011 Evid Based Complement Alternat Med pmid:19228775
Lin DS et al. The effects of sterol structure upon sterol esterification. 2010 Atherosclerosis pmid:19679306
Gylling H et al. Very high plant stanol intake and serum plant stanols and non-cholesterol sterols. 2010 Eur J Nutr pmid:19774436
Chen Q et al. Dietary phytosterols and phytostanols decrease cholesterol levels but increase blood pressure in WKY inbred rats in the absence of salt-loading. 2010 Nutr Metab (Lond) pmid:20637058
Méndez-González J et al. Disodium ascorbyl phytostanol phosphate (FM-VP4), a modified phytostanol, is a highly active hypocholesterolaemic agent that affects the enterohepatic circulation of both cholesterol and bile acids in mice. 2010 Br. J. Nutr. pmid:19822032
Schrøder M et al. Effect of rapeseed oil-derived plant sterol and stanol esters on atherosclerosis parameters in cholesterol-challenged heterozygous Watanabe heritable hyperlipidaemic rabbits. 2009 Br. J. Nutr. pmid:19772679
Weingärtner O et al. Controversial role of plant sterol esters in the management of hypercholesterolaemia. 2009 Eur. Heart J. pmid:19158117
Chen Q et al. Dietary phytosterols and phytostanols alter the expression of sterol-regulatory genes in SHRSP and WKY inbred rats. 2009 Ann. Nutr. Metab. pmid:19851062
Jia X et al. Co-administration of berberine and plant stanols synergistically reduces plasma cholesterol in rats. 2008 Atherosclerosis pmid:18430428